VALTIVE 1: A trial of a new blood test to find out which patients are responding to bevacizumab
In this study, researchers want to test a new blood test that they have developed which can tell doctors if a person is responding to the drug bevacizumab. Bevacizumab is a type of targeted therapy that works by blocking a growth factor (like a hormone) that makes blood vessels. This growth factor is called VEGF. By blocking VEGF, some cancers i…